What Verdica's 799 score means for NOVO
NOVO's composite score of 799 out of 850 places the entity in the "strong" performance band (740–799). This score reflects compliance and operational data aggregated from state pharmacy boards, the FDA, and DEA records. A score in this range indicates that NOVO meets or exceeds baseline regulatory requirements across the dimensions Verdica measures, with room for improvement in certain areas.
For a reader evaluating NOVO as a pharmacy provider, this score suggests a provider with solid compliance foundations. The entity is not in the highest tier (800–850, "excellent"), but it is well above the threshold of acceptability (670–739). This means NOVO has demonstrated consistent adherence to licensing, product approval, and federal compliance standards, though some sub-category performance lags slightly behind top-tier operators. No independent customer reviews are currently indexed for this entity, so this analysis is based entirely on regulatory data.
How the sub-scores break down
Product Approval (850 / 850): NOVO scores at the maximum in this dimension, indicating that all products in its portfolio meet FDA approval requirements. In the pharmacy industry, this is a foundational metric—products without proper approval cannot legally be dispensed. A perfect score here means Verdica found no evidence of unapproved, misbranded, or adulterated products in NOVO's offerings.
Manufacturer Profile (720 / 850): This is NOVO's lowest sub-score. The manufacturer profile dimension typically captures licensing status, facility inspection history, and compliance with good manufacturing practices (GMP) as tracked by state boards and the FDA. A score of 720 suggests NOVO maintains valid manufacturer credentials but may have minor compliance observations or gaps in certain operational standards. This is not a critical shortfall but indicates an area where processes or documentation could be strengthened.
FDA Compliance (830 / 850): NOVO scores highly in federal compliance, reflecting adherence to FDA regulations governing product quality, labeling, and reporting requirements. A score of 830 shows consistent compliance with federal standards, with only minor deviations from perfect performance. This suggests NOVO routinely meets its obligations to report adverse events, maintain product integrity, and follow FDA guidance.
What regulators track for pharmacy providers
State boards of pharmacy maintain licensure records, inspection reports, and disciplinary histories for all operating pharmacies and manufacturers. They monitor whether entities hold current licenses, have satisfied continuing education requirements, and remain free of substantive violations. Violations tracked include dispensing errors, diversion of controlled substances, inadequate record-keeping, and failure to comply with state-specific pharmacy laws.
The FDA oversees product approval, manufacturing quality, and post-market surveillance. The agency evaluates new drug applications (NDAs), verifies compliance with current good manufacturing practices, and monitors safety reports. FDA data includes inspection findings, warning letters, recalls, and product status.
The DEA tracks controlled substance handling and distribution. Compliance metrics include proper Chain of Custody documentation, inventory reconciliation, security protocols, and adherence to quotas for scheduled substances. Violations in this area—such as diversion, theft, or record falsification—carry serious consequences.
Verdica's composite scoring aggregates these regulatory data sources to produce a single risk profile. Scores move down when inspectors document deficiencies, products are recalled, licenses are suspended, or disciplinary action is taken. Scores move up when compliance records remain clean and entities proactively demonstrate regulatory adherence.
Bottom line
NOVO is a strong-performing provider with clean product approvals and solid federal compliance. Before engaging with NOVO, verify current licensing status through your state pharmacy board and confirm that product lines align with your procurement needs. The manufacturer profile sub-score warrants a follow-up conversation about any operational areas under development.